Antengene unveils three pipeline programs at AACR 2026 as AnTenGager platform expands beyond UCB deal
Can Kailera become the next major GLP-1 challenger after pricing one of biotech’s biggest IPOs in years?
Read More Pharma Industry News Fresenius Kabi launches generic Arsenic Trioxide Injection in US to enhance oncology treatment options German health care company Fresenius Kabi has announced the US launch of its new generic drug, Arsenic Trioxide… bypharmanewsdailyNovember 4, 2018
